DRUG · Mapped RxNorm record
Omalizumab
Normalized identity: omalizumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
NCT07425639
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Chronic Spontaneous Urticaria (CSU)unresolved
Allergic Asthmaverified · MONDO: allergic asthma
Interventions
OmalizumabDRUG · verified · RxNorm: omalizumab
Sponsors & collaborators
Celltrion HealthCare Francelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07425639 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.